Video
Testosterone therapy does not appear to worsen outcomes in men with COVID-19
Author(s):
Amarnath Rambhatla, MD, discusses findings from a study published online in the Journal of Sexual Medicine.
Video Player is loading.
In this interview, Amarnath Rambhatla, MD, discusses findings from the Journal of Sexual Medicine study, COVID-19 infection in men on testosterone therapy, for which he served as a study author. Rambhatla is director of men’s health at the Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan.
More videos:
Setting expectations in patients with prostate cancer receiving HIFU
HIFU for prostate cancer: How it works, criteria for treatment, and contraindications
Attorney Kenton H. Steele, Esq on the medico-legal dangers of friendly prescribing
Related Videos
Mohit Khera, MD, on the impact of penile prosthesis implant on mental health
Experts consider efficacy of fertility restoration vs sperm cryopreservation
Matthew Mutter, MD, shares data on Separo vessel sealing system for vasectomy
Fertility restoration may offer benefits in cost, efficacy vs sperm cryopreservation
Investigators discuss cost-effectiveness study of cryopreservation vs vasectomy reversal
Justin Dubin, MD, on potential health effects of SARMs and anabolic steroids
Study identifies trends in testosterone use in young adult men
Kristy L. Mardis, NP, on APP development initiatives in sexual medicine
Dr. Nam on potential future research on vasectomy in the post-Dobbs era
Dr. Nam on the increased interest in vasectomy amidst urologist shortages
Related Content
